Cytokinetics Inc. (CYTK) is a publicly traded Healthcare sector company. As of July 14, 2026, CYTK trades at $82.40 with a market cap of $11.52B and a P/E ratio of -11.91. CYTK moved +0.19% today. Year to date, CYTK is +34.01%; over the trailing twelve months it is +122.21%. Its 52-week range spans $29.31 to $88.31. Analyst consensus is strong buy with an average price target of $107.21. Rallies surfaces CYTK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Cytokinetics Inc. (CYTK) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CYTK moved +0.19% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $82.40 |
| Market Cap | $11.52B |
| P/E Ratio | -11.91 |
| EPS | $-6.84 |
| Dividend Yield | 0.00% |
| 52-Week High | $88.31 |
| 52-Week Low | $29.31 |
| Volume | 204 |
| Avg Volume | 0 |
| Revenue (TTM) | $105.81M |
| Net Income | $-829.61M |
| Gross Margin | 0.00% |
15 analysts cover CYTK: 0 strong buy, 13 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $107.21.